<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240107060643N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-01-03</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Investigating the synergy of three cognitive behavioral therapy methods, repeated transcranial magnetic stimulation, and transcranial direct current stimulation on major depression patients</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of synergestic effectiveness between cognitive behavioral therapy (CBT) and repeated transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) in cognitive flexibility, attention control, working memory and reducing signs and symptoms of MDD patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>65</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74984</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The samples are entered into four groups using simple randomization. Random assignment is done using Excel software. To do this, we enter sixteen numbers 1, sixteen numbers 2, sixteen numbers 3, and sixteen numbers 4 in the first column, which represent the three intervention groups and one control group, respectively. Then, we generate sixty-four random numbers in the second column using the (RAND) function. We sort the data (ascending or descending) based on the values ​​of the column containing the random numbers, Blinding description: The evaluator and data analyst are unaware of the type of intervention performed in the group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Major depression.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Cognitive behavioral therapy is performed in 12-16 sessions (45-60 minutes) according to the protocol (Leahy, 2012) twice a week. After the initial assessment and identification of the patient's problems, familiarization with the treatment begins. After that, intervention and training in cognitive and behavioral techniques are provided. Intervention 2: Intervention group: Each individual received repetitive transcranial magnetic stimulation (rTMS) at a frequency of 1 Hz, 20 minutes per session, 1200 pulses on the right dorsolateral prefrontal cortex (rDLPFC) and 10 Hz on the left dorsolateral prefrontal cortex (lDLPFC) for 20 minutes, 1600 pulses in total, 2800 pulses per session. Intervention 3: Control group: Control group: The group that receives one of the SSRI drugs at an antidepressant dose. Intervention 4: Intervention group: Combination of tDCS and drug therapy: The tDCS treatment program was implemented for the experimental group for 10 20-minute sessions (F3) and (F4). In direct current cranial wall stimulation treatment, two electrodes, one positive and the other negative, are placed on the head through a sponge pad soaked in a conductive solution. After passing through different areas (scalp, skull, etc.), the electric current through these electrodes reaches the surface of the cerebral cortex. The current that reaches this area charges the neurons and creates positive and negative poles, which leads to a change in the activity of that area.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Atabakhsh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Zanjan branch - Pain Kouh Blvd. - Daneshjo Blvd</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>58145-45156</zip>
        <telephone>+98 24 3346 9500</telephone>
        <email>alirezaatabakhsh12@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohsen Dadashi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Zanjan branch - Pain Kouh Blvd. - Daneshjo Blvd</address>
        <city>zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956184</zip>
        <telephone>024330180</telephone>
        <email>mohsendadashi@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All major depression patients
Subjects had to show symptoms of major depressive disorder confirmed by a psychiatrist according to the HDRS (21).
The participants had to complete a written consent form and were not exposed to any psychological or complementary treatment for at least one month before entering the study.
Carrying metal or other electrical devices on the head or having wounds and scratches on the scalp.
Absent contraindications to tDCS, such as metal in the head or medical devices implanted in the brain, experience at least Three AHs per week
Age: 18 to 65 years old</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Risk of suicide,
History of epilepsy and seizures
Presence of an electrical or metal object in the body
Presence of any neurological disease that affects the central nervous system (such as Parkinson's)
Pregnancy
Co-occurring bipolar disorder
Psychosis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F33.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, recurrent severe without psychotic features</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Cognitive behavioral therapy is performed in 12-16 sessions (45-60 minutes) according to the protocol (Leahy, 2012) twice a week. After the initial assessment and identification of the patient's problems, familiarization with the treatment begins. After that, intervention and training in cognitive and behavioral techniques are provided.</i_keyword>
      <i_keyword>Intervention group: Each individual received repetitive transcranial magnetic stimulation (rTMS) at a frequency of 1 Hz, 20 minutes per session, 1200 pulses on the right dorsolateral prefrontal cortex (rDLPFC) and 10 Hz on the left dorsolateral prefrontal cortex (lDLPFC) for 20 minutes, 1600 pulses in total, 2800 pulses per session.</i_keyword>
      <i_keyword>Control group: Control group: The group that receives one of the SSRI drugs at an antidepressant dose.</i_keyword>
      <i_keyword>Intervention group: Combination of tDCS and drug therapy: The tDCS treatment program was implemented for the experimental group for 10 20-minute sessions (F3) and (F4). In direct current cranial wall stimulation treatment, two electrodes, one positive and the other negative, are placed on the head through a sponge pad soaked in a conductive solution. After passing through different areas (scalp, skull, etc.), the electric current through these electrodes reaches the surface of the cerebral cortex. The current that reaches this area charges the neurons and creates positive and negative poles, which leads to a change in the activity of that area.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The individual's score on Hamilton Depression Rating Scale (HDRS). Timepoint: Measuring the severity of depressive symptoms before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: Hamiltonian measurement test.</prim_outcome>
      <prim_outcome>Wisconsin Cognitive Flexibility Test (WCST) score. Timepoint: Measuring the individual's WCST score before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: Wisconsin Cognitive Task (WCST) by Sina Software.</prim_outcome>
      <prim_outcome>Working memory score in the N-BACK test. Timepoint: Measuring the individual's N-BACK score before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: N-BACK working memory cognitive task by Sina Software.</prim_outcome>
      <prim_outcome>Cognitive selective attention score in the simple Stroop test. Timepoint: Measuring the individual's score on the simple stroop task before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: Simple Stroop cognitive attention and concentration task by Sina Company software.</prim_outcome>
      <prim_outcome>Cognitive attention inhibition score in the GONOGO test. Timepoint: Measuring the individual's score on the GONOGO task before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: Cognitive task of attention inhibition by Sina Company software.</prim_outcome>
      <prim_outcome>The individual's score on the beck Depression Inventory(BDI). Timepoint: Measuring the severity of depressive symptoms before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: he individual's score on Beck Depression Inventory (BDI).</prim_outcome>
      <prim_outcome>The individual's score on the Montgomery-Aasberg Depression Rating Scale (MADRS). Timepoint: Measuring the severity of depressive symptoms before the intervention, immediately after the intervention, and one month after the intervention as a follow-up. Method of measurement: Montgomery-Asberg Depression Scale (MADRS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-20</approval_date>
        <contact_name>Islamic Azad University - Zanjan Branch (Research Ethics Committee)</contact_name>
        <contact_address>Islamic Azad University, Zanjan Branch - Arazi Payin Kooh Road - Daneshjoo Blvd. Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
